Trial Profile
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolaemic Hyponatraemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Aug 2016
Price :
$35
*
At a glance
- Drugs Lixivaptan (Primary)
- Indications Hyponatraemia
- Focus Pharmacokinetics; Registrational
- Sponsors Cardiokine
- 12 Aug 2014 New trial record
- 24 Nov 2010
- 24 Mar 2010